MicroRNAs are important players in head and neck carcinoma: A review

Critical Reviews in Oncology/Hematology

Volumn 88, Issue 3, 2013, Pages 716-728

  Janiszewska, Joanna ^a   Szaumkessel, Marcin ^a   Szyfter, Krzysztof ^a,b  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

DNA methylation; Expression; Head and neck squamous cell carcinoma (HNSCC); MiRNA; Prognostic markers; Review

Indexed keywords

MICRORNA; MICRORNA 125A; MICRORNA 133A; MICRORNA 137; MICRORNA 138; MICRORNA 16; MICRORNA 181; MICRORNA 181B; MICRORNA 184; MICRORNA 200A; MICRORNA 204; MICRORNA 205; MICRORNA 21; MICRORNA 210; MICRORNA 211; MICRORNA 221; MICRORNA 222; MICRORNA 24; MICRORNA 30A 5P; MICRORNA 31; MICRORNA 345; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR MARKER; UNCLASSIFIED DRUG;

CANCER PROGNOSIS; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEAD AND NECK CARCINOMA; HUMAN; OVERALL SURVIVAL; REVIEW; TUMOR GROWTH; UPREGULATION; WART VIRUS;

DNA METHYLATION; EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC); MIRNA; PROGNOSTIC MARKERS; REVIEW;

ALPHAPAPILLOMAVIRUS; ANIMALS; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; PROGNOSIS;

EID: 84888303104     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2013.07.012     Document Type: Review

References (113)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2012, 62:10-29.
2. Lajer C.B., von Buchwald C. The role of human papillomavirus in head and neck cancer. Apmis 2012, 118:510-519.
3. Kim L., King T., Agulnik M. Head and neck cancer: changing epidemiology and public health implications. Oncology (Williston Park) 2010, 24:915-919. 24.
4. Iorio M.V., Croce C.M. microRNA involvement in human cancer. Carcinogenesis 2012, 33:1126-1133.
5. Lujambio A., Lowe S.W. The microcosmos of cancer. Nature 2012, 482:347-355.
6. Macfarlane L.A., Murphy P.R. MicroRNA: biogenesis, function and role in cancer. Current Genomics 2010, 11:537-561.
7. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Research 2011, 39:D152-D157.
8. Jiang J., Lee E.J., Gusev Y., Schmittgen T.D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Research 2005, 33:5394-5403.
9. Tran N., McLean T., Zhang X., et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochemical and Biophysical Research Communications 2007, 358:12-17.
10. Chang S.S., Jiang W.W., Smith I., et al. MicroRNA alterations in head and neck squamous cell carcinoma. International Journal of Cancer 2008, 123:2791-2797.
11. Avissar M., Christensen B.C., Kelsey K.T., Marsit C.J. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clinical Cancer Research 2009, 15:2850-2855.
12. Cervigne N.K., Reis P.P., Machado J., et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Human Molecular Genetics 2009, 18:4818-4829.
13. Childs G., Fazzari M., Kung G., et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. American Journal of Pathology 2009, 174:736-745.
14. Ramdas L., Giri U., Ashorn C.L., et al. miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head and Neck 2009, 31:642-654.
15. Kimura S., Naganuma S., Susuki D., et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncology Reports 2010, 23:1625-1633.
16. Cao P., Zhou L., Zhang J., et al. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma. Head and Neck 2012.
17. Hui A.B., Lenarduzzi M., Krushel T., et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clinical Cancer Research 2010, 16:1129-1139.
18. Chen Z., Jin Y., Yu D., et al. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncology 2012.
19. Fu X., Han Y., Wu Y., et al. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. European Journal of Clinical Investigation 2011, 41:1245-1253.
20. Markou A., Tsaroucha E.G., Kaklamanis L., Fotinou M., Georgoulias V., Lianidou E.S. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clinical Chemistry 2008, 54:1696-1704.
21. Baffa R., Fassan M., Volinia S., et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. Journal of Pathology 2009, 219:214-221.
22. Barker E.V., Cervigne N.K., Reis P.P., et al. microRNA evaluation of unknown primary lesions in the head and neck. Molecular Cancer 2009, 8:127.
23. Liu X., Chen Z., Yu J., Xia J., Zhou X. MicroRNA profiling and head and neck cancer. Comparative and Functional Genomics 2009, 837514.
24. Wiklund E.D., Gao S., Hulf T., et al. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS ONE 2011, 6:e27840.
25. Fletcher A.M., Heaford A.C., Trask D.K. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Translational Oncology 2008, 1:202-208.
26. Hebert C., Norris K., Scheper M.A., Nikitakis N., Sauk J.J. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Molecular Cancer 2007, 6:5.
27. Wong T.S., Liu X.B., Wong B.Y., Ng R.W., Yuen A.P., Wei W.I. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clinical Cancer Research 2008, 14:2588-2592.
28. Kozaki K., Imoto I., Mogi S., Omura K., Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Research 2008, 68:2094-2105.
29. Park N.J., Zhou H., Elashoff D., et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clinical Cancer Research 2009, 15:5473-5477.
30. Wald A.I., Hoskins E.E., Wells S.I., Ferris R.L., Khan S.A. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head and Neck 2011, 33:504-512.
31. Nohata N., Hanazawa T., Kikkawa N., et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). Journal of Human Genetics 2011, 56:595-601.
32. Harris T., Jimenez L., Kawachi N., et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. American Journal of Pathology 2012, 180:917-928.
33. Hsu C.M., Lin P.M., Wang Y.M., Chen Z.J., Lin S.F., Yang M.Y. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biology 2012.
34. Wang P., Fu T., Wang X., Zhu W. Primary, study of miRNA expression patterns in laryngeal carcinoma by microarray. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010, 24:535-538.
35. Lajer C.B., Nielsen F.C., Friis-Hansen L., et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. British Journal of Cancer 2011, 104:830-840.
36. Patel R.S., Jakymiw A., Yao B., et al. High resolution of microRNA signatures in human whole saliva. Archives of Oral Biology 2011, 56:1506-1513.
37. Lin S.C., Liu C.J., Lin J.A., Chiang W.F., Hung P.S., Chang K.W. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncology 2010, 46:204-208.
38. Liu C.J., Lin S.C., Yang C.C., Cheng H.W., Chang K.W. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head and Neck 2012, 34:219-224.
39. Wong T.S., Ho W.K., Chan J.Y., Ng R.W., Wei W.I. Mature miR-184 and squamous cell carcinoma of the tongue. TheScientificWorldJournal 2009, 9:130-132.
40. Yang C.C., Hung P.S., Wang P.W., et al. miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 2011, 40:397-404.
41. Wendt T.G., Bank P. Prognostic factors in squamous cell carcinoma of the head and neck. Onkologie 2002, 25:208-212.
42. Kowalski L.P., Sanabria A. Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhinolaryngologica Italica 2007, 27:113-117.
43. Chang K.W., Liu C.J., Chu T.H., et al. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. Journal of Dental Research 2008, 87:1063-1068.
44. Sun Q., Zhang J., Cao W., et al. Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. International Journal of Biochemistry and Cell Biology 2013, 45:513-520.
45. Li J., Huang H., Sun L., et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clinical Cancer Research 2009, 15:3998-4008.
46. Yang Y., Ahn Y.H., Gibbons D.L., et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. Journal of Clinical Investigation 2011, 121:1373-1385.
47. Langevin S.M., Stone R.A., Bunker C.H., Grandis J.R., Sobol R.W., Taioli E. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis 2010, 31:864-870.
48. Gee H.E., Camps C., Buffa F.M., et al. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010, 116:2148-2158.
49. Lenarduzzi M., Hui A.B., Alajez N.M., et al. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. PLoS ONE 2013, 8:e53765.
50. Lee Y., Yang X., Huang Y., et al. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Computational Biology 2010, 6:e1000730.
51. Liu X., Jiang L., Wang A., Yu J., Shi F., Zhou X. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Letters 2009, 286:217-222.
52. Liu X., Yu J., Jiang L., et al. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics & Proteomics 2009, 6:131-139.
53. Kinoshita T., Nohata N., Watanabe-Takano H., et al. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma. International Journal of Oncology 2012, 40:1770-1778.
54. Jung H.M., Phillips B.L., Patel R.S., et al. Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing-cysteine-rich protein with kazal motifs (RECK) in oral cancer. Journal of Biological Chemistry 2012.
55. Lu Z., Liu M., Stribinskis V., et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008, 27:4373-4379.
56. Bourguignon L.Y., Earle C., Wong G., Spevak C.C., Krueger K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 2012, 31:149-160.
57. Liu M., Wu H., Liu T., et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Research 2009, 19:828-837.
58. Reis P.P., Tomenson M., Cervigne N.K., et al. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Molecular Cancer 2010, 9:238.
59. Ren J., Zhu D., Liu M., Sun Y., Tian L. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. European Journal of Cancer 2010, 46:3409-3416.
60. Poy M.N., Eliasson L., Krutzfeldt J., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
61. Lee K.M., Choi E.J., Kim I.A. microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiotherapy and Oncology 2011, 101:171-176.
62. Sarkar D., Park E.S., Emdad L., Lee S.G., Su Z.Z., Fisher P.B. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Research 2008, 68:1478-1484.
63. Yoo B.K., Emdad L., Su Z.Z., et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. Journal of Clinical Investigation 2009, 119:465-477.
64. Liu Z., Wei S., Ma H., et al. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2011, 32:1668-1674.
65. Jiang L., Dai Y., Liu X., et al. Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. Human Genetics 2011, 129:189-197.
66. Jin Y., Wang C., Liu X., et al. Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. Journal of Biological Chemistry 2011, 286:40104-40109.
67. Liu X., Wang C., Chen Z., et al. MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochemical Journal 2011, 440:23-31.
68. Nohata N., Hanazawa T., Kikkawa N., et al. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. International Journal of Oncology 2011, 38:209-217.
69. Kinoshita T., Nohata N., Fuse M., et al. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma. Biochemical and Biophysical Research Communications 2012, 418:378-383.
70. Mutallip M., Nohata N., Hanazawa T., et al. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133alpha in head and neck squamous cell carcinoma (HNSCC). International Journal of Molecular Medicine 2011, 27:345-352.
71. Susuki D., Kimura S., Naganuma S., et al. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma. Cancer Science 2011, 102:2164-2171.
72. Jiang L., Liu X., Chen Z., et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochemical Journal 2010, 432:199-205.
73. Tsai Y.S., Lin C.S., Chiang S.L., Lee C.H., Lee K.W., Ko Y.C. Areca nut induces miR-23a and inhibits repair of DNA double-strand breaks by targeting FANCG. Toxicological Sciences 2011, 123:480-490.
74. Uesugi A., Kozaki K., Tsuruta T., et al. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Research 2011, 71:5765-5778.
75. Liu C.J., Tsai M.M., Hung P.S., et al. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Research 2010, 70:1635-1644.
76. Zhang L., Sun Z.J., Bian Y., Kulkarni A.B. MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Letters 2013, 331:230-238.
77. Shin K.H., Bae S.D., Hong H.S., Kim R.H., Kang M.K., Park N.H. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochemical and Biophysical Research Communications 2011, 404:896-902.
78. Hatakeyama H., Cheng H., Wirth P., et al. Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. PLoS ONE 2010, 5:e12702.
79. Dai Y., Xie C.H., Neis J.P., Fan C.Y., Vural E., Spring P.M. MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance. Head and Neck 2011, 33:786-791.
80. Yu T., Wang X.Y., Gong R.G., et al. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. Journal of Experimental and Clinical Cancer Research 2009, 28:64.
81. Hummel R., Watson D.I., Smith C., et al. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. Journal of Gastrointestinal Surgery 2011, 15:429-438.
82. Long X.B., Sun G.B., Hu S., et al. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncology Reports 2009, 22:1189-1195.
83. Yu C.C., Chen Y.W., Chiou G.Y., et al. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncology 2011, 47:202-210.
84. Cai K.M., Bao X.L., Kong X.H., et al. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. International Journal of Molecular Medicine 2010, 25:565-571.
85. Kumar B., Yadav A., Lang J., Teknos T.N., Kumar P. Dysregulation of MicroRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS ONE 2012, 7:e37601.
86. Henson B.J., Bhattacharjee S., O'Dee D.M., Feingold E., Gollin S.M. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes, Chromosomes and Cancer 2009, 48:569-582.
87. Yang C.J., Shen W.G., Liu C.J., et al. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. Journal of Oral Pathology and Medicine 2011, 40:560-566.
88. Zhang T., Liu M., Wang C., Lin C., Sun Y., Jin D. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Research 2011, 31:3859-3863.
89. Nohata N., Sone Y., Hanazawa T., et al. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2011, 2:29-42.
90. Wang F., Song G., Liu M., Li X., Tang H. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Letters 2011, 585:3263-3269.
91. Hunt S., Jones A.V., Hinsley E.E., Whawell S.A., Lambert D.W. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Letters 2011, 585:187-192.
92. Yang M.H., Lin B.R., Chang C.H., et al. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 2012, 31:2401-2411.
93. Liu X., Wang A., Heidbreder C.E., et al. MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS Letters 2010, 584:4115-4120.
94. Datta J., Smith A., Lang J.C., et al. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cvarepsilon. Oncogene 2011.
95. Piao L., Zhang M., Datta J., et al. Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. Molecular Therapy 2012, 20:1261-1269.
96. Wong T.S., Liu X.B., Chung-Wai Ho A., Po-Wing Yuen A., Wai-Man Ng R., Ignace Wei W. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. International Journal of Cancer 2008, 123:251-257.
97. Janssen H.L., Reesink H.W., Lawitz E.J., et al. Treatment of HCV infection by targeting microRNA. New England Journal of Medicine 2013, 368:1685-1694.
98. Yan B., Fu Q., Lai L., et al. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells. Molecular Medicine Reports 2012, 6:675-681.
99. Xiao W., Bao Z.X., Zhang C.Y., et al. Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia. PLoS ONE 2012, 7:e38648.
100. Szyf M. Heterogeneous DNA methylation as an early marker of cancer. Epigenomics 2012, 4:13-14.
101. Dumitrescu R.G. Epigenetic markers of early tumor development. Methods in Molecular Biology 2012, 863:3-14.
102. Lujambio A., Calin G.A., Villanueva A., et al. A microRNA DNA methylation signature for human cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:13556-13561.
103. Minor J., Wang X., Zhang F., et al. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncology 2012, 48:73-78.
104. Kreimer A.R., Clifford G.M., Boyle P., Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiology, Biomarkers and Prevention 2005, 14:467-475.
105. Shridhar R., Shridhar V., Wang X., et al. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Research 1996, 56:4347-4350.
106. Thorland E.C., Myers S.L., Persing D.H., et al. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Research 2000, 60:5916-5921.
107. Cannizzaro L.A., Durst M., Mendez M.J., Hecht B.K., Hecht F. Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genetics and Cytogenetics 1988, 33:93-98.
108. Tran N., Rose B.R., O'Brien C.J. Role of human papillomavirus in the etiology of head and neck cancer. Head and Neck 2007, 29:64-70.
109. Vidal L., Gillison M.L. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematology/Oncology Clinics of North America 2008, 22:1125-1142. vii.
110. Lajer C.B., Garnaes E., Friis-Hansen L., et al. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. British Journal of Cancer 2012.
111. Lu F., Weidmer A., Liu C.G., Volinia S., Croce C.M., Lieberman P.M. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. Journal of Virology 2008, 82:10436-10443.
112. Miska E.A., Alvarez-Saavedra E., Townsend M., et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biology 2004, 5:R68.
113. Califano J., van der Riet P., Westra W., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Research 1996, 56:2488-2492.